10-K.Info (Beta Test)
Courtesy of Short Sands, LLC
10-K.Info (Beta Test)
Courtesy of Short Sands, LLC

GILEAD SCIENCES, INC.

Ticker: GILD   Fiscal Year: 2015

Consolidated Statements of Income

Period Ending Dec 31, 2015 10-K (Filed: Feb 24, 2016)

(In Millions)
 12 Months Ended12 Months Ended12 Months Ended
 Dec 31, 2015Dec 31, 2014Dec 31, 2013
Revenues
Product sales
$
32,151
24,47410,804
Royalty, contract and other revenues488416398
Total revenues32,63924,89011,202
 
Costs and Expenses
Cost of goods sold4,0063,7882,859
Research and development expenses3,0142,8542,120
Selling, general and administrative expenses3,4262,9831,699
Total costs and expenses10,4469,6256,678
 
Income from operations22,19315,2654,524
Interest expense(688)(412)(307)
Other income (expense), net1543(9)
Income before provision for income taxes21,65914,8564,208
 
Provision for income taxes3,5532,7971,151
Net income18,10612,0593,057
 
Net loss attributable to noncontrolling interest(2)(42)(18)
Net income attributable to Gilead18,10812,1013,075
 
Net income per share attributable to Gilead common stockholders - basic (in US$ per share)12.377.952.01
Shares used in per share calculation - basic1,4641,5221,529
Net income per share attributable to Gilead common stockholders - diluted (in US$ per share)11.917.351.81
Shares used in per share calculation - diluted1,5211,6471,695
Cash dividends declared per share (in US$ per share)1.290.000.00
External Links 
GILEAD SCIENCES, INC. (GILD) Fiscal Year 2015
Statements of 10-K in Excel https://www.sec.gov/.../Financial.xlxs
Complete 10-K in HTML https://www.sec.gov/.../10-K.html
Complete 10-K in XBRL https://www.sec.gov/.../10-K-xbrl.zip